Syneos Health

Syneos Health is a fully integrated biopharmaceutical solutions organisation, combining clinical development, medical affairs and commercial expertise to support biopharmaceutical companies from early-phase development through product launch and beyond. The firm employs approximately 29,000 people and maintains a presence in 110 countries, working across the pharmaceutical, oncology and life sciences sectors.

Its offering rests on an integrated model that links clinical, medical and commercial capabilities within a single engagement. Customers can also contract specific functions through functional service provider (FSP) partnerships or place work in a full-service environment for end-to-end trial delivery. The company reports that, over recent five-year periods, it helped develop or commercialise 96% of novel oncology drugs approved by the FDA and 93% of oncology products granted marketing authorisation by the EMA.

Syneos Health describes its culture as collaborative and mission-driven, centred on accelerating the delivery of therapies to patients and translating insights into outcomes for customers. The company emphasises problem-solving and responsiveness to current market conditions in the biopharmaceutical industry.